ArticleAdvances in experimental medicine and biology2026
State and Trait Anxiety in Patients with Neurological Diseases During COVID Pandemic.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPatients with neurological diseases frequently experience anxiety that may exacerbate during the COVID-19 pandemic due to social isolation and prevailing conditions in every society. The purpose of this research study was to explore state and trait anxiety among patients with neurological diseases during the period of COVID-19. MATERIAL AND
methodIn the present study were enrolled 100 patients with neurological diseases who visited for regular re-evaluation the outpatient clinics of a private hospital in Attica. Data were collected by the method of interview using the State-Trait Anxiety Inventory Scale-STAI, which included patients' characteristics. The level of statistical significance was set at p < 0.05.
resultsOf the 100 participants, 62% were female, while 52% of the sample was over 60 years old. In terms of anxiety, 50% had scores less than 34.5 and 38 (median) on the scale of state and trait anxiety, respectively (range 20-80). These values indicate moderate to low levels of state and trait anxiety. Statistically significantly higher state and trait anxiety was experienced by patients who were less informed about their disease (p = 0.008 and p = 0.014, respectively) and those who wished to receive information about the pandemic via mass media (p = 0.027 and p = 0.035, respectively). Statistically significantly higher trait anxiety was reported by single patients (p = 0.037), and those experiencing intra-family conflicts (p = 0.008), while higher state anxiety was reported by patients who had mobility problems and other illnesses (p = 0.050 and p = 0.044, respectively).
conclusionsThe coronavirus disease 2019 (COVID-19) is a public health issue of global interest and a challenge to address anxiety.
Indexed as
Identifiers
41273576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.